Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/119789
Full metadata record
DC FieldValueLanguage
dc.creatorCláudia Ferreira Batista Rosa
dc.date.accessioned2025-11-07T16:17:20Z-
dc.date.available2025-11-07T16:17:20Z-
dc.date.issued2019-05-15
dc.date.submitted2019-03-21
dc.identifier.othersigarra:333746
dc.identifier.urihttps://hdl.handle.net/10216/119789-
dc.language.isopor
dc.rightsrestrictedAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectMedicina clínica
dc.subjectClinical medicine
dc.titleEculizumab e o Síndrome Hemolítico Urémico Atípico
dc.typeDissertação
dc.contributor.uportoFaculdade de Medicina
dc.identifier.doi10.34626/sr4n-yd16
dc.identifier.tid202406776
dc.subject.fosCiências médicas e da saúde::Medicina clínica
dc.subject.fosMedical and Health sciences::Clinical medicine
thesis.degree.disciplineMestrado Integrado em Medicina
thesis.degree.grantorFaculdade de Medicina
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:FMUP - Dissertação

Files in This Item:
File Description SizeFormat 
333746.pdf
  Restricted Access
Eculizumab e o Síndrome Hemolítico Urémico Atípico3.65 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons